National Health Investors, Inc. (NYSE:NHI) Sees Large Growth in Short Interest

National Health Investors, Inc. (NYSE:NHI) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 3,740,952 shares, a growth of 102.4% from the June 15th total of 1,847,936 shares. Currently, 7.9% of the company’s shares are short sold. Based on an average trading volume of 1,574,464 shares, the days-to-cover ratio is presently 2.4 days.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on NHI. Deutsche Bank Aktiengesellschaft decreased their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Wells Fargo & Company cut their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. Truist Financial decreased their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. BMO Capital Markets lowered their price objective on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research note on Wednesday, April 22nd. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, National Health Investors has an average rating of “Moderate Buy” and a consensus price target of $83.86.

Insider Activity

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Several institutional investors and hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC purchased a new position in shares of National Health Investors during the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors during the 4th quarter valued at approximately $33,000. GAMMA Investing LLC boosted its position in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new position in shares of National Health Investors during the 4th quarter worth approximately $47,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Up 4.3%

Shares of National Health Investors stock traded up $3.26 during midday trading on Thursday, reaching $79.10. 503,127 shares of the company’s stock traded hands, compared to its average volume of 983,747. The stock has a 50 day moving average of $74.36 and a 200-day moving average of $79.60. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The company has a market cap of $3.83 billion, a PE ratio of 25.52, a price-to-earnings-growth ratio of 3.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.7%. National Health Investors’s dividend payout ratio is 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.